Europe

NuMedii, Inc announced the formation of a strategic partnership with Three Lakes Partners, LLC, to discover and advance new treatments for idiopathic pulmonary fibrosis (IPF) based on NuMedii’s Big Data intelligence technology. Idiopathic pulmonary fibrosis is a rare chronic progressive and usually fatal interstitial lung disease for which the origin is unknown.…
GlaxoSmithKline (GSK) opened its expanded antibiotics facility in Irvine in February 2016. The Irvine plant produces GSK's antibiotic drugs, including potassium clavulanate that is sold under the brand name Augmentin. Construction on the facility's expansion began in 2013, with the aim to expand the antibiotics production capacity to serve 100…
A ground-breaking collaborative project, driven by Epilepsy Scotland, together with two pharmaceutical companies, to develop and improve epilepsy services for adults in Dumfries & Galloway, was today recognised at the Scottish Parliament. The story of the transformation of care for epilepsy patients in the region, which includes the creation of…
As part of the United States regulatory approval process for new medicines, new uses of existing medicines and the continuous monitoring of safety, companies may be required to conduct additional studies and testing to support the safety and effectiveness of their medicines. In the European Union (EU) companies can be…
In the second quarter of 2003 the Swedish vaccine producer, SBL Vaccin AB, brought on-line a major extension and upgrade to the vaccine production facility at Solna near Stockholm. The company has been in various hands and used to be a subsidiary of Powderject PLC, which acquired the company in…
Page 1 of 5

Subscribe To Our Newsletter

Security Q:How many eyes has a typical person? (ex: 1)
Name:
Email: